Distributed Ledger Technology (DLT) is pivotal in this use case as it introduces a level of transparency, security, and efficiency previously unattainable with traditional data management systems. Blockchain ensures that all data related to clinical trials is immutable and traceable, which is crucial for maintaining integrity and trust. Smart contracts automate access and permissions, reducing the potential for human error and bias while ensuring compliance with regulations. Furthermore, DLT enables real-time tracking and automated incentivization, enhancing stakeholder engagement and ensuring that contributions are acknowledged and rewarded, thus fostering a cooperative and productive environment.